GF Fund Management’s 89bio ETNB Stock Holding History

GF Fund Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,191	Closed	-$46.9K	–	662
2025 Q3	$46.9K	Buy	3,191 +180	+6%	+$1.83K	﹤0.01%	399
2025 Q2	$29.6K	Hold	3,011	–	–	﹤0.01%	461
2025 Q1	$21.9K	Buy	3,011 +542	+22%	+$4.74K	﹤0.01%	495
2024 Q4	$19.3K	Buy	+2,469	New	+$20.3K	﹤0.01%	474

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GF Fund Management's ETNB Position: Q4 2025 in Review

GF Fund Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 3,191 shares — an estimated $46.9K sold.

GF Fund Management first reported a position in ETNB in Q4 2024 and held it in 4 quarters. The position peaked at $46.9K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

GF Fund Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
GF Fund Management sold 3,191 89bio shares in Q4 2025, an estimated $46.9K.
GF Fund Management first reported a position in 89bio in Q4 2024 and held it in 4 quarters.
GF Fund Management's 89bio position peaked at $46.9K in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.